The CARDIOMEMS HF system is indicated for the wireless measurement and monitoring of pulmonary artery pressure in patients with heart failure NYHA (NEWYORK HEART ASSOCIATION) class III who have been hospitalized for heart failure during the previous year. The hemodynamic data allow doctors to treat heart failure and reduce hospitalizations for this condition. The doctor can use the CARARDOMS HF system in the hospital or the office to perform pulmonary blood pressure measurements and analyze them. The patient can use the CARDIOMEMS HF system in his home to make and send hemodynamic measurements and pulmonary arterial depression wirelessly to a secure database for analysis and evaluation by the physician.
CD1377-36C, CD1377-36QC, CD2377-36C and CD2377-36QC
Descripción del producto
Designed to administer ventricular antitachycardia and ventricular defibrillation for the automatic treatment of ventricular arrhythmias that endanger the life of the patient. Addition of indication: indication for magnetic resonance imaging, for MRI cardioid defibrillators models CD2377-36Q, CD2377-36QC, CD1377-36Q, CD1377-36QC and QUADRAASSURA cardioid defibrillators models CD3367-40QC, CD3367-40Q and QUADRAASSURA MP models CD3371-40QC, CD3371- 40Q. The cardiofibrillators FORTIFY ASSURA DR models CD2359-40Q, CD2359- CD2359-40QC, and FORTIFY ASSURAVR models CD1359-40Q, CD1359-40QC; they are conditional to magnetic resonance, the use of these devices conditionally safe in the MRI environment if a conditional DAI system is used to complete MRI.
Patients with alterations in the generation and / or conduction of the cardiac electrical impulse. Pulse generators or pacemakers with magnetic resonance imaging (MRI) are conditionally safe in the MRI environment (magnetic resonance imaging) if a complete MRI system is used and in accordance with the instructions for use
Neurostimulation system GENESIS: is indicated as an aid in the treatment of chronic pain, not treatable with other therapies of the trunk or extremities including unilateral or bilateral pain associated with any of the following cases: syndrome of failure of the back surgery, as well as back pain and pain in lower limbs difficult to cure. EON / EON MINI neurostimulation system: are indicated for the treatment of chronic and intractable pain of the trunk and / or extremities, including unilateral or bilateral pain associated with some of the following cases; failure syndrome of back surgery, as well as low back pain and pain in lower limbs difficult to cure. MULTIPROGRAM TRIALSTIMULATOR system: it is used for the stimulation of the spinal cord (eme) in the treatment of chronic trunk pain and extremities, either as an individual palliative method or with other types of treatment in the case of pluridisciplinary therapy. This system of modular stimulation is indicated as adjuvant in the treatment of chronic pain in the trunk and extremities, including unilateral or bilateral pain associated with angina pectoris and peripheral vascular disease.
The NANOSTIM wireless pacemaker is indicated for: 1. Chronic atrial fibrillation with second-degree AV block or bifascicular branch block. 2. Inaugural rhythms with second or third degree AV block or branch block and a low level of physical activity or a low expected life expectancy. 3. Sinus bradycardia with pausasaislated or unexplained syncope with electrophysiological results. Uses: the wireless pacemaker NANOSTIM is a pulse generator designed for bradycardia stimulation that incorporates a battery and electrodes and must be implanted in the right ventricle. Since it is a cordless device, it does not need a connector, stimulation cable or pulse generator pocket. A non-retractable distal helix with a single twist fixes the device to the endocardium. In addition, three sutures in the outer part of the head of the device offer a secondary fixation. Detection and stimulation occur between a distal electrode near the helix and the external housing of the device. The proximal end of the device has a mechanism that allows coupling it to the decolocation and extraction catheters for repositioning and extraction. The device is communicated bidirectionally with the programmer by electrical signals that are processed between the electrodes of the implanted device and the skin electrodes attached to the patient's chest and connected to the programmer. Accordingly, the device transmits signals by circuits and electrodes previously designed for stimulation, with data encoded by pulses during the refractory period of the heart. The device detects the blood temperature of the right ventricle and increases the frequency of stimulation as the metabolic requirement increases.
It is a rotational left ventricular axial flow assist system and can generate flows of up to 10 liters per minute (LPM) attached to the apex of the left ventricle and the ascending aorta, blood labomba HEARMATE II diverts the blood from the weakened left ventricle and pushes it towards the rest of the body. The controller of the system, through its internal software program regulates the pumping.